clemastine has been researched along with albuterol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Handslip, PD; Hartley, JP; Hurst, NP; Nogrady, SG | 1 |
| Hodges, IG; Milner, AD; Stokes, GM | 1 |
| Groggins, RC; Milner, AD; Stokes, GM | 1 |
| Bratton, DL; Lester, MR | 1 |
2 review(s) available for clemastine and albuterol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Adverse reactions to cromolyn sodium: patient report and review of the literature.
Topics: Albuterol; Anti-Allergic Agents; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Beclomethasone; Bronchodilator Agents; Child, Preschool; Clemastine; Cromolyn Sodium; Humans; Male; Prednisone; Theophylline; Urination Disorders; Vesico-Ureteral Reflux | 1997 |
3 trial(s) available for clemastine and albuterol
| Article | Year |
|---|---|
Bronchodilatation after inhalation of the antihistamine clemastine.
Topics: Adult; Aerosols; Aged; Albuterol; Asthma; Bronchi; Clemastine; Forced Expiratory Volume; Humans; Middle Aged; Peak Expiratory Flow Rate; Placebos; Pyrrolidines; Time Factors | 1978 |
Bronchodilator effect of two inhaled H1-receptor antagonists, clemastine and chlorpheniramine, in wheezy school-children.
Topics: Albuterol; Asthma; Bronchi; Child; Child, Preschool; Chlorpheniramine; Clemastine; Clinical Trials as Topic; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Peak Expiratory Flow Rate; Pyrrolidines | 1983 |
Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma.
Topics: Airway Resistance; Albuterol; Asthma; Atropine Derivatives; Bronchodilator Agents; Child, Preschool; Clemastine; Female; Humans; Ipratropium; Male; Peak Expiratory Flow Rate; Pyrrolidines | 1981 |
3 other study(ies) available for clemastine and albuterol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |